hyaluronoglucosaminidase has been researched along with Acute Confusional Senile Dementia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Li, X; Yang, R; Zhang, X; Zheng, J | 1 |
Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
Bajda, M; Czarnecka, K; Galita, G; Girek, M; Jończyk, J; Kabziński, J; Kręcisz, P; Majsterek, I; Skibiński, R; Szymański, P; Szymczyk, P; Walczak, A; Wójtowicz, P; Łątka, K | 1 |
Jeon, JP; Kim, JH; Shim, SM | 1 |
Bajda, M; Czarnecka, K; Girek, M; Jończyk, J; Kabziński, J; Maciejewska, K; Majsterek, I; Skibiński, R; Sołowiej, P; Szymański, P | 1 |
Vocadlo, DJ; Yuzwa, SA | 1 |
3 review(s) available for hyaluronoglucosaminidase and Acute Confusional Senile Dementia
Article | Year |
---|---|
The Role of Heparin and Glycocalyx in Blood-Brain Barrier Dysfunction.
Topics: Alzheimer Disease; Blood-Brain Barrier; Brain Ischemia; Endothelium, Vascular; Epilepsy; Glucuronidase; Glycocalyx; Heparin; Humans; Hyaluronoglucosaminidase; Matrix Metalloproteinases; Multiple Sclerosis; Nervous System Diseases; Shear Strength; Stroke | 2021 |
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Topics: Acetylglucosamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antigens, Neoplasm; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases; tau Proteins | 2014 |
3 other study(ies) available for hyaluronoglucosaminidase and Acute Confusional Senile Dementia
Article | Year |
---|---|
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Catalytic Domain; Cell Line, Tumor; Cells, Cultured; Chlorobenzoates; Cholinesterase Inhibitors; Cholinesterases; Free Radical Scavengers; Humans; Hyaluronoglucosaminidase; Mice; Molecular Docking Simulation; Neuroprotective Agents; Protein Binding; Protein Multimerization; Tacrine | 2020 |
Effective litmus gene test for monitoring the quality of blood samples: Application to Alzheimer's disease diagnostics.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biomarkers; Case-Control Studies; Cell Line, Tumor; Chemokine CCL20; Cognitive Dysfunction; Female; Humans; Hyaluronoglucosaminidase; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Middle Aged; Proteins | 2017 |
New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Aminoquinolines; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Proliferation; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Eels; Glycoside Hydrolase Inhibitors; Horses; Humans; Hyaluronoglucosaminidase; Models, Molecular; Molecular Structure; Niacinamide; Peptide Fragments; Protein Aggregates; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |